<DOC>
	<DOCNO>NCT02660385</DOCNO>
	<brief_summary>Chronic insomnia may contribute development exacerbation heart failure ( HF ) , incident mortality contribute common disabling symptom ( fatigue , dyspnea , anxiety , depression , excessive daytime sleepiness , pain ) decrement objective subjective functional performance . The purpose study evaluate sustain effect CBT-I insomnia severity , sleep characteristic , daytime symptom , functional performance twelve month among patient stable chronic HF chronic insomnia . The effect treatment outcome HF ( hospitalization , death ) cost treatment also examine . A total 200 participant randomize 4 bi-weekly group session cognitive behavioral therapy CBT-I ( behavioral improve insomnia sleep ) HF self-management education . Participants complete wrist actigraph ( wrist-watch like accelerometer ) measure sleep , diary , reaction time , 6 minute walk test distance . They also complete self-report measure insomnia , sleep , symptom , functional performance . In addition effect symptoms function period one year .</brief_summary>
	<brief_title>Insomnia Self-Management Heart Failure</brief_title>
	<detailed_description>Almost 75 % HF patient , group 5.1 million Americans poor function high level morbidity mortality , report poor sleep . As many 25-56 % HF patient report chronic insomnia ( difficulty initiate maintain sleep wake early morning , non-restorative sleep persists least month ) . Chronic insomnia may contribute development exacerbation HF incident mortality . It also associate common disabling symptom ( fatigue , dyspnea , anxiety , depression , excessive daytime sleepiness , pain ) decrement objective subjective functional performance.However , insomnia under-diagnosed under-treated population . Cognitive behavioral therapy insomnia ( CBT-I ) multi-modal behavioral treatment focus modify belief attitude sleep efficacious many population . The purpose RCT evaluate sustain effect CBT-I , compare HF self-management education ( attention control ) , insomnia severity , sleep characteristic , daytime symptom , functional performance twelve month among patient stable chronic HF chronic insomnia receive evidence-based HF disease management . We also evaluate cost-effectiveness CBT-I compare attention-control condition explore effect CBT-I event-free survival . We address follow specific aim ( *primary outcome ) : ( 1 ) Test sustain effect ( baseline - 2 week , 6 , 9 , 12 month ) CBT-I provide 4 group session 8 week , compare HF self-management education ( attention control condition ) , : ( 1a ) *insomnia severity self-reported actigraph-recorded sleep characteristic ( *sleep quality , *sleep efficiency , sleep latency , duration ) ; ( 1b ) symptom ( *fatigue , anxiety , depression , pain , sleepiness , sleep-related impairment ) , psychomotor vigilance ( PVT ) ; ( 1c ) symptom cluster [ membership cluster characterize severity specific symptom ; transition cluster time ] ; ( 2 ) Test sustain effect CBT-I self-reported objective functional performance ; ( 3 ) Examine cost-effectiveness CBT-I . Exploratory aim : We explore effect CBT-I event-free survival . A total 200 patient randomize 4 bi-weekly session group CBT-I attention control condition consist HF self-management education . Wrist actigraph measure sleep , diary , psychomotor vigilance 6 minute walk test distance , self-report measure insomnia , sleep , symptom , functional performance obtain baseline follow-up . Data analysis consist mixed effect model , latent transition analysis , stochastic cost-effectiveness analysis , survival analysis .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Depression</mesh_term>
	<criteria>stable chronic heart failure , chronic insomnia , English speaking/reading , untreated sleep disorder breathe restless legs syndrome , rotating/night shift work , active illicit drug use , bipolar disorder , neuromuscular condition affect nondominant arm endstage renal failure , significant cognitive impairment , unstable medical psychiatric disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>pain</keyword>
	<keyword>insomnia</keyword>
	<keyword>cardiac failure</keyword>
	<keyword>sleep</keyword>
	<keyword>fatigue</keyword>
	<keyword>heart disease</keyword>
	<keyword>anxiety</keyword>
	<keyword>actigraphy</keyword>
	<keyword>psychomotor vigilance</keyword>
	<keyword>six minute walk</keyword>
	<keyword>depression</keyword>
	<keyword>cognitive behavioral therapy</keyword>
	<keyword>self-management</keyword>
	<keyword>self-care</keyword>
</DOC>